| Disease | DISCUSSION OF A CLINICAL TRIAL INVOLVING 12 SUBJECTS STARTING IN NOVEMBER 1989. TREATMENT WILL BE FOR 4 WEEKS AT DOSES OF 8, 16, 24 AND 36 MCG/KG EVERY WEEK FOR 4 WEEKS.
EXCLUSION CRITERIA: ANTIVIRALS WITHIN 3 WEEKS PRIOR TO ENTRY, SYSTEMATIC CHEMOTHERAPY LESS THAN 6 WEEKS PRIOR TO ENTRY.
STUDY SITES ARE: AIDS COMMUNITY RESEARCH CONSORTIUM(REDWOOD CITY,CA), PORTON MEDICAL GROUP(SHERMAN OAKS,CA), ST.FRANCIS MEMORIAL HOSPITAL(SAN FRANCISCO), U. OF CALIFORNIA MEDICAL CENTER(SAN FRANCISCO) AND VIRX MEDICAL GROUP(SAN FRANCISCO).
INCLUSION CRITERIA: PLATELETS MORE THAN 100,000, SGOT/PT LESS THAN 1.5 X NORMAL, BILIRUBIN NORMAL, GRANULOCYTES GREATER THAN 1000, AGE GREATER THAN 18 YEARS, KAMOFSKY SCORE MORE THAN 80. |